AzTrials
AzTrials

Behavior and Behavior MechanismsNCT04842500

Translational Research to Inform Interventions for Challenging Behavior

A study testing Demand Informed Moderator Analysis in people with Behavior and Behavior Mechanisms, run by Vanderbilt University at 5 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This project is meant to identify relations between the reinforcement histories of 80 adults with intellectual and developmental disabilities (IDD) and the prevalence of extinction bursts. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Behavior and Behavior Mechanisms
What is being tested?
Demand Informed Moderator Analysis
Could I receive a placebo?
No, everyone receives an active treatment
How many people
86 participants
Where
5 sitesUnited States
Study dates
1 Aug 2021to 14 May 2024
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Participants must be older than 18.
  • Participants must have a developmental disability (unconstrained to specific diagnoses).
  • Participants must be able to correctly manipulate all items used in the study.
  • Participants must consent (or assent, when relevant) to procedures prior to and throughout the study.

Who cannot join

  • Participants younger than 18.
  • Participants without disabilities.
  • Participants who cannot correctly manipulate items used in the study.
  • Participants who do not consent (or assent, when relevant) to participation.

Trial locations and contacts

5 sites in 1 country.

5 sites in 1 country

United States5 sites
  • Habilitative and Training Services (HATS)

    Gallatin, Tennessee, 37066

  • Easterseals Tennessee: Prospect

    Lebanon, Tennessee, 37060

  • Possibility Place

    Murfreesboro, Tennessee, 37133

  • Next Steps at Vanderbilt

    Nashville, Tennessee, 37203

  • Chrysalis

    Orem, Utah, 84057

Other trials in United States

About this study

Official title: Translational Research to Inform Interventions for Severe Challenging Behavior for Individuals With Intellectual and Developmental Disabilities

This project is meant to identify relations between the reinforcement histories of 80 adults with intellectual and developmental disabilities (IDD) and the prevalence of extinction bursts. Extinction bursts, or temporary increases in rates and intensities of behavior during extinction, often preclude the inclusion of extinction in intervention packages meant to suppress severe challenging behavior, despite the fact that extinction is often necessary to generate therapeutic outcomes. Study results will provide insight into how researchers can enhance interventions for the severe challenging behavior of individuals with IDD while mitigating the undesirable collateral effects (i.e., extinction bursts) of therapeutic action (i.e., extinction). Expanded access to study results will be made available to those who inquire after all data have been obtained and analyzed.

Read the detailed description

The Goal of this project is to identify mechanisms responsible for bursts, and to facilitate strategic extensions toward discovery for treatments of challenging behavior. AIM 1: In the service of this goal, the investigators aim to evaluate the accuracy of an efficient alternative to demand-curve analysis (i.e., progressive ratio reinforcer analysis) in quantifying reinforcer value (i.e., Pmax). AIM 2: Investigators also aim to evaluate the utility of manipulating baseline reinforcement parameters for controlling bursts when those manipulations are informed by the results of demand-curve analysis.

Being tested
Demand Informed Moderator Analysis
Keywords
behavioral sciences, reinforcement schedule, motivation, economics, behavioral, developmental disability, intellectual disability, problem behavior, extinction bursts
Medical subject headings
Behavior, Developmental Disabilities, Intellectual Disability, Problem Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Demand Informed Moderator AnalysisBehavioural

    This analysis is designed to determine the degree to which relative price, and the timing of extinction, interact to increase or abate responding during extinction (thereby highlighting mechanisms of control).

Study groups in NCT04842500
Study groupRoleWhat they receive
"Cheap" Unit Price, Establishing OperationExperimentalPre-extinction baseline unit price for the programmed reinforcer will be its Pmax, minus one half of the distance between its Pmax and its breakpoint. Extinction will be introduced at the beginning of the relevant appointment, before within-appointment reinforcer consumption has had an opportunity to approximate demand.
Receives: Behavioral: Demand Informed Moderator Analysis
"Cheap" Unit Price, Abolishing OperationExperimentalPre-extinction baseline unit price for the programmed reinforcer will be its Pmax, minus one half of the distance between its Pmax and its breakpoint. Extinction will be introduced at the end of the relevant appointment, after within-appointment reinforcer consumption has approximated demand.
Receives: Behavioral: Demand Informed Moderator Analysis
"Expensive" Unit Price, Establishing OperationExperimentalPre-extinction baseline unit price for the programmed reinforcer will be its Pmax, plus one half of the distance between its Pmax and its breakpoint. Extinction will be introduced at the beginning of the relevant appointment, before within-appointment reinforcer consumption has had an opportunity to approximate demand.
Receives: Behavioral: Demand Informed Moderator Analysis
"Expensive" Unit Price, Abolishing OperationExperimentalPre-extinction baseline unit price for the programmed reinforcer will be its Pmax, plus one half of the distance between its Pmax and its breakpoint. Extinction will be introduced at the end of the relevant appointment, after within-appointment reinforcer consumption has approximated demand.
Receives: Behavioral: Demand Informed Moderator Analysis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Peak Response Rate During Extinction

    This term describes the highest rate of responding observed during extinction and will be depicted as a proportion of baseline. For example, assuming the mean rate of responding during the final three sessions of baseline is 3 responses per minute (i.e., [2.8 rpm + 3.2 rpm + 3 rpm] / 3 = 3 rpm), and the highest rate of responding during a single session of extinction is 3.4 rpm, then peak response rate for this hypothetical individual would be 1.13 (i.e., 3.4 / 3 = 1.13). This value will serve as the primary dependent variable for each participant in all between-groups comparisons in our data-analysis plan.

    Measured: This measure was obtained throughout the primary assessment (i.e., the extinction challenge)

  2. Schedule Value at Breakpoint

    The progressive-ratio reinforcer analysis (PRA) is a game of diminishing returns that is considered an assessment of reinforcer value (e.g., if a participant does not value the reinforcer, they will quit sooner than a participant that does value the reinforcer). During the assessment, we increased the "price" (i.e., the schedule value) of reinforcers each time a participant earns two reinforcers at a currently established price.

    The breakpoint describes the "price" (schedule value; e.g., FR1, FR4, FR7) of the last obtained reinforcer prior to response cessation (i.e., the breakpoint is the last schedule value that supported enough responding to produce a reinforcer, before the participant quit playing the game). Higher breakpoints are interpreted as reflecting higher-value reinforcers. Lower breakpoints are interpreted as reflecting lower-value reinforcers.

    Measured: PRA breakpoints were obtained during pre-assessment and were used as a matching variable prior to random assignment.

  3. The Schedule Value Designated as Pmax

    The progressive fixed-ratio reinforcer analysis (PFRA) is an assessment of consumer demand that first establishes how much of a reinforcer a participant would consume when consumption is free of constraint (i.e., when participants can have as much of the reinforcer as they want; referred to as "bliss-point consumption").

    With bliss-point consumption established, PFRA evaluates how much a participant will "spend" (respond) to maintain bliss-point consumption patterns as price (schedule value) is increased. Unlike PRA, prices in the PFRA are held constant within each session and only increase across sessions. Initially, participants "spend" more. Eventually, they "spend" less. The price that produces maximum "spending" (i.e., higher and lower prices yield lower response outputs) is referred to as Pmax.

    Pmax is one way to quantify a reinforcer's value. That is, reinforcers that produce high Pmax have more value than reinforcers that produce low Pmax.

    Measured: Pmax values were obtained during pre-assessment and were used as a scaling variable to set baseline schedule parameters.

  4. Response Latency

    This term describes the latency from session onset to eventual response cessation during the extinction challenge.

    Measured: This measure was obtained throughout the primary assessment (i.e., the extinction challenge)

Secondary outcomes (2)
  1. Number of Sessions in Extinction

    In addition to between-groups differences in peak-response rate (primary dependent variable), the investigators will also compare between-groups differences in the number of sessions required to achieve response elimination during extinction.

    Measured: This measure was obtained throughout the primary assessment (i.e., the extinction challenge)

  2. Overall Session Duration

    The investigators will measure the total duration of PFRA sessions (in seconds) at Pmax to establish baseline-session parameters.

    Measured: Duration values were obtained during pre-assessment and were used as a scaling variable to set baseline schedule parameters.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Apr 2021
  2. Study start1 Aug 2021
  3. Primary completion24 May 2023
  4. Study completion14 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Model description
The investigators will enroll 80 adults with developmental disabilities in a low-stakes translational investigation employing a 2x2 factorial, crossed, and randomized matched blocks design, with batched randomization logic. Procedures will include: (a) matching participants within batches according to progressive ratio reinforcer analysis results, and (b) randomly assigning participants to one of four experimental conditions to determine whether information about reinforcer value can be used to set baseline parameters that either promote or eliminate bursts during extinction.
Masking
Single blind
Who is masked
Participant
Enrolment
86 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04842500
Sponsor's protocol ID
IRB #202204
Status last verified
Jan 2025
First submitted
4 Apr 2021
Last updated
6 Feb 2025
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Peer-reviewed published empirical reports will follow CONSORT reporting guidelines, as well as other principles of rigor and transparency highlighted through the Equator network (https://www.equator-network.org/).

Questions about this trial

What is this clinical trial studying?

A study testing Demand Informed Moderator Analysis in people with Behavior and Behavior Mechanisms, run by Vanderbilt University at 5 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 6 Feb 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Peak Response Rate During Extinction (time frame: This measure was obtained throughout the primary assessment (i.e., the extinction challenge)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2025; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in